Failure of early administration of antithymocyte globulin to lessen graft-versus-host disease in human allogeneic marrow transplant recipients.
D000961:Antilymphocyte Serum / Q000494:pharmacology*; D016026:Bone Marrow Transplantation; D006086:Graft vs Host Disease / Q000628:therapy; D006087:Graft vs Host Reaction / Q000187:drug effects*; D006801:Humans; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors
D000961:Antilymphocyte Serum